Observational studyAnnals of African medicine2026
Fetomaternal Outcome in Obstetric Cholestasis in a Tertiary Care Hospital.
Observational study in Annals of African medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIntrahepatic cholestasis is a potentially serious condition that can develop during the late half of pregnancy. It can increase the risk of preterm birth and stillbirth in fetus and postpartum hemorrhage in mothers. The main symptoms are severe pruritus. Since this condition is hormone-induced, it is a reversible condition and likely to recur in subsequent pregnancy. Early diagnosis, adequate treatment, and well-timed delivery are imperative for better maternal and fetal outcomes. MATERIALS AND
methodsThis is a prospective observational study done in a tertiary care center, RIMS, Ranchi, Jharkhand. Data were collected from 203 affected pregnant females from July 2023 to June 2024. Proper history, examination, and investigations were done.
resultsThe incidence was found to be 2.62% in our hospital. Women of 26-30 years were affected mostly (33.99%). 53.69% were from rural areas and belonged to the lower middle socioeconomic class. Primigravidae were affected more (45.81%). Jaundice was the most common complication (8.87%). Postpartum hemorrhage was observed in 8.87% of cases. 28.5% had preterm delivery. Intrauterine fetal death was seen in 4.43% and 1.97% had stillbirth in women affected with the disorder. Liver enzymes were significantly raised.
conclusionIt affects the fetal outcome adversely, resulting in preterm birth, fetal distress, stillbirth, meconium aspiration, and respiratory distress syndrome. There is a high risk of postpartum hemorrhage in mothers. Proper counseling, investigations, and treatment with ursodeoxycholic acid will help in alleviating the symptoms and result in a better outcome for the mother and fetus. It is a self-limiting condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.